RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway - PubMed (original) (raw)

. 2017 Aug 28:402:153-165.

doi: 10.1016/j.canlet.2017.05.024. Epub 2017 Jun 6.

Wanqin Liao 1, Li Zhang 1, Xi Tu 2, Jin Hu 1, Tianke Chen 1, Xiaowei Dai 1, Yan Xiong 1, Weicheng Liang 1, Chaodong Ding 1, Rui Liu 1, Juji Dai 1, Ouchen Wang 3, Liting Lu 1, Xincheng Lu 4

Affiliations

RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway

Xiaoming Dong et al. Cancer Lett. 2017.

Abstract

R-spondins play critical roles in development, stem cell survival, and tumorigenicity by modulating Wnt/β-catenin signaling; however, the role of R-spondins in noncanonical Wnt signaling regulation remains largely unknown. We demonstrate here that R-spondin 2 (RSPO2) has an inhibitory effect on colorectal cancer (CRC) cell migration, invasion, and metastasis. Reduced RSPO2 expression was associated with tumor metastasis and poor survival in CRC patients. The metastasis-suppressive activity of RSPO2 was independent of the Wnt/β-catenin signaling pathway but dependent on the Fzd7-mediated noncanonical Wnt signaling pathway. The physical interaction of RSPO2 and Fzd7 increased the degradation of cell surface Fzd7 via ZNRF3-mediated ubiquitination, which led to the suppression of the downstream PKC/ERK signaling cascade. In late-stage metastatic cancer, Wnt5a promoted CRC cell migration by preventing degradation of Fzd7, and RSPO2 antagonized Wnt5a-driven noncanonical Wnt signaling activation and tumor cell migration by blocking the binding of Wnt5a to the Fzd7 receptor. Our study reveals a novel RSPO2/Wnt5a-competing noncanonical Wnt signaling mechanism that regulates cellular migration and invasion, and our data suggest that secreted RSPO2 protein could serve as a potential therapy for Wnt5a/Fzd7-driven aggressive CRC tumors.

Keywords: Colorectal cancer; Fzd7; Metastasis; RSPO2; Wnt5a.

Copyright © 2017 Elsevier B.V. All rights reserved.

PubMed Disclaimer

MeSH terms

Substances

LinkOut - more resources